William Blair Weighs in on Avantor, Inc.’s Q3 2024 Earnings (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTR) – Stock analysts at William Blair decreased their Q3 2024 earnings per share estimates for shares of Avantor in a research note issued to investors on Monday, April 29th. William Blair analyst M. Larew now expects that the company will post earnings per share of $0.26 for the quarter, down from their prior forecast of $0.27. The consensus estimate for Avantor’s current full-year earnings is $1.01 per share. William Blair also issued estimates for Avantor’s Q1 2025 earnings at $0.28 EPS, Q3 2025 earnings at $0.33 EPS, Q4 2025 earnings at $0.38 EPS and FY2025 earnings at $1.28 EPS.

Avantor (NYSE:AVTR) last posted its earnings results on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.15%. The company’s revenue was down 5.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.29 EPS.

A number of other research analysts have also recently commented on AVTR. Deutsche Bank Aktiengesellschaft boosted their price objective on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research note on Thursday, April 18th. Barclays upped their price target on Avantor from $27.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, April 10th. UBS Group lifted their price objective on shares of Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, February 15th. Robert W. Baird reduced their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday. Finally, Royal Bank of Canada raised their price target on shares of Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Avantor currently has a consensus rating of “Moderate Buy” and an average target price of $26.71.

Avantor Stock Performance

NYSE:AVTR opened at $24.08 on Tuesday. Avantor has a twelve month low of $16.63 and a twelve month high of $26.16. The firm has a market capitalization of $16.33 billion, a price-to-earnings ratio of 61.74, a PEG ratio of 2.44 and a beta of 1.37. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 1.00. The firm’s fifty day simple moving average is $25.09 and its 200 day simple moving average is $22.66.

Insiders Place Their Bets

In related news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the completion of the transaction, the executive vice president now owns 101,143 shares in the company, valued at approximately $2,476,992.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of AVTR. Raymond James & Associates grew its stake in shares of Avantor by 84.8% in the fourth quarter. Raymond James & Associates now owns 1,165,646 shares of the company’s stock worth $26,612,000 after purchasing an additional 534,901 shares in the last quarter. Federated Hermes Inc. increased its stake in Avantor by 19.9% during the 4th quarter. Federated Hermes Inc. now owns 628,189 shares of the company’s stock valued at $14,342,000 after buying an additional 104,296 shares during the period. DAVENPORT & Co LLC raised its position in shares of Avantor by 17.6% during the 4th quarter. DAVENPORT & Co LLC now owns 2,283,767 shares of the company’s stock worth $52,430,000 after buying an additional 342,452 shares in the last quarter. Vaughan Nelson Investment Management L.P. boosted its stake in Avantor by 8.4% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 2,508,557 shares of the company’s stock valued at $57,269,000 after purchasing an additional 194,031 shares in the last quarter. Finally, Northern Trust Corp increased its position in shares of Avantor by 9.0% during the 3rd quarter. Northern Trust Corp now owns 4,129,447 shares of the company’s stock valued at $87,049,000 after purchasing an additional 342,553 shares during the period. Institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.